Maryland 2025 Regular Session

Maryland House Bill HB1086

Introduced
2/5/25  
Refer
2/5/25  
Report Pass
3/12/25  
Engrossed
3/13/25  
Refer
3/17/25  
Report Pass
4/4/25  
Enrolled
4/7/25  
Chaptered
5/20/25  

Caption

Maryland Medical Assistance Program and Health Insurance - Coverage for Anesthesia - Prohibiting Time Limitations

Impact

The implications of HB1086 will be significant for both consumers and providers. Patients will benefit by ensuring that they receive comprehensive anesthesia coverage, eliminating potential gaps in care that could arise from time-based restrictions. The bill targets the insurance practices that could delay or limit the availability of necessary medical procedures, reinforcing the importance of continuous care during surgical processes. Importantly, the bill will come into effect on January 1, 2026, which allows time for health plans to adjust their policies and systems to comply with the new regulations. This change could potentially lead to improved patient satisfaction and safety in healthcare delivery.

Summary

House Bill 1086 aims to amend the Maryland Medical Assistance Program and health insurance policies by ensuring that coverage for anesthesia is provided without time limitations. This legislation mandates that if an insured individual receives anesthesia for a procedure prescribed by a licensed medical professional, their health plan must cover the delivery of anesthesia for the full duration of the procedure, along with the immediate care required before and after. The bill delineates specific regulations that insurers and health maintenance organizations must follow to comply with this requirement, thereby enhancing patient care standards across the state.

Sentiment

The general sentiment surrounding HB1086 appears to be positive, particularly among healthcare professionals and patient advocacy groups. Supporters argue that this legislation aligns with best practices in medicine, emphasizing the need for uninterrupted care during surgical procedures. Conversely, challenges may arise regarding how insurance companies adapt to these new requirements and manage their coverage polices. There seems to be a collective recognition that while the bill significantly benefits patient care, it may also require rigorous implementation oversight to ensure insurers are compliant.

Contention

Notably, one contention point that may arise relates to the capacity of insurers to absorb the changes without passing on costs to consumers. While the intent is to enhance patient care, there is a concern about the potential for higher premiums as insurers adapt to provide the mandated level of anesthesia coverage. Stakeholders may debate the balance between improved patient outcomes and the financial implications for health insurance providers, which could affect policyholders' ability to afford coverage.

Companion Bills

No companion bills found.

Previously Filed As

MD SB805

Maryland Medical Assistance Program and Health Insurance – Required Coverage for Biomarker Testing

MD HB1217

Maryland Medical Assistance Program and Health Insurance - Required Coverage for Biomarker Testing

MD HB400

Maryland Medical Assistance Program and Health Insurance - Annual Behavioral Health Wellness Visits - Coverage and Reimbursement

MD HB1137

Maryland Medical Assistance Program and Health Insurance - Required Coverage for Calcium Score Testing

MD SB124

Maryland Medical Assistance Program and Health Insurance - Annual Behavioral Health Wellness Visits - Coverage and Reimbursement

MD SB497

Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products

MD HB1376

Maryland Medical Assistance Program, Maryland Children's Health Program, and Health Insurance - Special Pediatric Hospitals

MD SB614

Maryland Medical Assistance Program and Health Insurance - Coverage for Prostheses (So Every Body Can Move Act)

MD HB865

Maryland Medical Assistance Program and Health Insurance - Coverage for Prostheses (So Every Body Can Move Act)

MD HB736

Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products (NARCAN Price Cap Act)

Similar Bills

MD HB55

Health Occupations - Nurse Anesthetists - Drug Authority

MD SB1011

Health Occupations - Nurse Anesthetists - Drug Authority

MD SB312

Health Occupations - Nurse Anesthetists - Drug Authority and Collaboration

MD HB1146

Maryland Department of Health and Maryland Health Care Commission - Dental Services - Survey and Regional Needs Assessment

MD HB1097

State Board of Veterinary Medical Examiners - Veterinary Technicians and Veterinary Assistants

MD HB464

Health Occupations – Practice Audiology – Definition

MD SB795

Health Occupations - Practice Audiology - Definition

MD SB919

Health Occupations – Practice of Audiology – Definition